Inactive Instrument
Artemis Therapeutics Inc Stock OTC Bulletin Board
Stocks
US04302Q1094
Biotechnology & Medical Research
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Shimon Citron
CEO | Chief Executive Officer | 72 | 30/06/2022 |
David Dana
DFI | Director of Finance/CFO | 62 | 26/07/2022 |
Haim Tabak
COO | Chief Operating Officer | 78 | 01/01/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Shimon Citron
BRD | Director/Board Member | 72 | 30/06/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 11.2K | ||
| +2.38% | +3.43% | +82.88% | +115.89% | 73.96B | ||
| +0.87% | +17.34% | +57.17% | +97.28% | 64.66B | ||
| -4.27% | -0.99% | -3.38% | +475.61% | 27.32B | ||
| -1.97% | +20.38% | -0.37% | +0.48% | 27.86B | ||
| +1.53% | +11.65% | +60.92% | +26.63% | 25.97B | ||
| -0.51% | +5.73% | +38.71% | -12.79% | 19.98B | ||
| -1.79% | -4.84% | +239.54% | +414.48% | 17.84B | ||
| +1.78% | +4.23% | +19.55% | +538.24% | 16.24B | ||
| -1.29% | +6.09% | +41.81% | +154.45% | 13.3B | ||
| Average | -0.33% | +6.18% | +59.65% | +201.14% | 31.9B | |
| Weighted average by Cap. | +0.24% | +8.21% | +60.00% | +161.93% |
Employees
-
















